Almitas Capital LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001596468
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 76 positions · Total reported value $240.51M · Top-10 concentration 52.3% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 50.7% · 35 new · 21 cut · 20 exited
Active Share (vs S&P 500): 99.4% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +1.7% · vs SPY -13.1% · Prev Value $442.55M — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2024 13F filing, Almitas Capital LLC disclosed 76 equity positions with a combined reported value of $240.51M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.3% of reported value. HoldingsHub classifies the profile as Small / Financials Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were BMEZ ($27.06M), NPCT ($16.06M), ECAT ($14.72M). By sector, the heaviest allocations are Financials 53.7%, Health Care 5.6%. Versus the prior quarter, allocation shifted toward Financials (+11.4pp), Health Care (+3.6pp) and away from Real Estate (-1.4pp), Other (-13.1pp).
Versus the prior quarter, Almitas Capital LLC opened 35 new positions, trimmed 21 and fully exited 20, a turnover rate of 50.7% of positions. The portfolio's overlap with the prior quarter was 58% of names.
The largest new positions opened in Q2 2024 were AVIR ($4.27M), BTX ($3.93M), AMLX ($3.62M).
Of the 20 positions fully exited versus the prior quarter, the largest were AJXA ($22.26M), FIF ($7.58M), FEN ($6.33M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- AVIR ATEA PHARMACEUTICALS INC · $4.27M
- BTX BLACKROCK TECH AND PRIVATE E · $3.93M
- AMLX AMYLYX PHARMACEUTICALS INC · $3.62M
- IGI WESTERN ASSET INVT GRADE OPP · $3.58M
- GDO WSTRN AST GLBL CORP OPP FD INC COM · $2.48M
- CBH VIRTUS · $2.45M
- SLRN ACELYRIN INC · $1.66M
- BTT BLACKROCK MUN TARGET TERM TR COM SHS BEN IN · $1.61M
Fully Exited (vs previous quarter)
- AJXA GREAT AJAX CORP · prev qtr: $22.26M
- FIF FIRST TR ENERGY INFRASTRCTR · prev qtr: $7.58M
- FEN FIRST TR ENERGY INCOME & GRO · prev qtr: $6.33M
- CEM CLEARBRIDGE · prev qtr: $2.86M
- HTY HANCOCK JOHN INVT TR · prev qtr: $2.82M
- CTR CLEARBRIDGE ENERGY MLP TOTAL · prev qtr: $2.72M
- CET Central Secs Corp · prev qtr: $2.07M
- FEI FIRST TR MLP & ENERGY INCOM · prev qtr: $2.05M
Insider Transactions (Form 4)
Latest Almitas Capital LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Almitas Capital LLC is an SEC-registered 13F filer based in Santa Monica, CA, United States. As of Q2 2026 it reported 130 US equity positions with a combined value of $417.36M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: SANTA MONICA, CA, United States
- SEC registration: 801-108002 (status: Approved), registered 2016-06-30
- Regulatory AUM (Form ADV): $1.07B as of 2026-05-08
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 2 hedge funds
- Website: almitascap.com
Portfolio Structure
- 130 positions · $417.36M reported value (Q2 2026)
- Top 10 holdings = 52.4% of reported value
- Largest position: FBTC (FIDELITY WISE ORIGIN BITCOIN FUND) at 16.7%
- Average position size: $3.21M
Sector Tilt
- Financials 63.7%
- Health Care 14.4%
- Industrials 7.8%
- (classified holdings cover 95% of value)
Quarterly Activity
- Q2 2026: 35 new, 31 added, 21 reduced, 20 exited
- 43 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.76M | $27.06M | 11.25% | Add | |
| 2 |
|
1.48M | $16.06M | 6.68% | Reduce | |
| 3 |
|
839.10K | $14.72M | 6.12% | Add | |
| 4 |
|
1.18M | $14.44M | 6.00% | Add | |
| 5 |
|
1.11M | $12.40M | 5.16% | Add | |
| 6 |
|
501.90K | $9.76M | 4.06% | Add | |
| 7 |
|
500.41K | $8.30M | 3.45% | Add | |
| 8 |
|
526.47K | $8.07M | 3.36% | Add | |
| 9 |
|
180.72K | $7.76M | 3.23% | Add | |
| 10 |
|
730.15K | $7.20M | 2.99% | Reduce | |
| 11 |
|
791.10K | $5.69M | 2.37% | Add | |
| 12 |
|
606.92K | $4.45M | 1.85% | Reduce | |
| 13 |
|
1.29M | $4.27M | 1.78% | New | |
| 14 |
|
116.62K | $4.22M | 1.75% | Add | |
| 15 |
|
1.25M | $4.20M | 1.75% | Add | |
| 16 |
|
514.70K | $4.15M | 1.73% | Add | |
| 17 |
|
543.25K | $3.93M | 1.63% | New | |
| 18 |
|
353.25K | $3.87M | 1.61% | Add | |
| 19 |
|
477.45K | $3.77M | 1.57% | Reduce | |
| 20 |
|
1.90M | $3.62M | 1.50% | New | |
| 21 |
|
209.34K | $3.58M | 1.49% | New | |
| 22 |
|
67.06K | $3.33M | 1.39% | Reduce | |
| 23 |
|
559.40K | $3.32M | 1.38% | Add | |
| 24 |
|
219.89K | $3.20M | 1.33% | Reduce | |
| 25 |
|
114.75K | $3.07M | 1.28% | Add | |
| 26 |
|
360.85K | $2.74M | 1.14% | Add | |
| 27 |
|
276.62K | $2.73M | 1.13% | Add | |
| 28 |
|
722.55K | $2.68M | 1.11% | Reduce | |
| 29 |
|
202.72K | $2.48M | 1.03% | New | |
| 30 |
|
271.76K | $2.45M | 1.02% | New | |
| 31 |
|
165.06K | $1.98M | 0.82% | Reduce | |
| 32 |
|
363.15K | $1.95M | 0.81% | Add | |
| 33 |
|
177.28K | $1.93M | 0.80% | Reduce | |
| 34 |
|
183.11K | $1.74M | 0.72% | Reduce | |
| 35 |
|
108.25K | $1.73M | 0.72% | Reduce | |
| 36 |
|
184.86K | $1.69M | 0.70% | Hold | |
| 37 |
|
153.38K | $1.67M | 0.69% | Add | |
| 38 |
|
149.90K | $1.67M | 0.69% | Add | |
| 39 |
|
376.12K | $1.66M | 0.69% | New | |
| 40 |
|
456.18K | $1.63M | 0.68% | Reduce | |
| 41 |
|
138.87K | $1.62M | 0.67% | Hold | |
| 42 |
|
77.39K | $1.61M | 0.67% | New | |
| 43 |
|
1.61M | $1.57M | 0.65% | Reduce | |
| 44 |
|
223.37K | $1.27M | 0.53% | Add | |
| 45 |
|
27.64K | $1.21M | 0.51% | Reduce | |
| 46 |
|
53.22K | $1.19M | 0.49% | Reduce | |
| 47 |
|
920.23K | $1.14M | 0.47% | Hold | |
| 48 |
|
110.82K | $1.13M | 0.47% | Reduce | |
| 49 |
|
96.69K | $1.09M | 0.45% | Reduce | |
| 50 |
|
185.14K | $1.08M | 0.45% | Hold | |
FAQ
What did Almitas Capital LLC buy in 2024-Q2?
In its 2024-Q2 13F filing, Almitas Capital LLC reported 76 equity positions worth $240.51M in aggregate; its largest disclosed positions were BMEZ ($27.06M), NPCT ($16.06M), ECAT ($14.72M).
How large is Almitas Capital LLC's portfolio?
Almitas Capital LLC reported $240.51M of long equity holdings across 76 positions as of 2024-Q2. Top-10 holdings account for 52.3% of reported value.
What is Almitas Capital LLC's investment style?
HoldingsHub classifies the portfolio as Small / Financials Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.